GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS,

GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS, 2020 – 2028

GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET, 2020 – 2028

PAGE NO. | 2 COPYRIGHT © 2021 ZION MARKET RESEARCH

About Us

Zion Market Research (ZMR) is a market intelligence company providing global business

information reports and services. Our exclusive blend of quantitative forecasting and trends

analysis provides forward-looking insight for thousands of decision makers. ZMR’s

experienced team of Analysts, Researchers, and Consultants uses proprietary data source

and various tools and techniques to gather and analyze information. Our business offerings

represent the latest and the most reliable information indispensable for businesses to

sustain a competitive edge.

Each ZMR research report covers a different sector — such as pharmaceuticals, chemical,

energy, food and beverages, semiconductors, medical devices, consumer goods, and

technology. These reports provide in-depth analysis and deep segmentation to possible

micro levels. With wider scope and stratified research methodology, our syndicated reports

strive to serve the overall research requirement of clients.

Copyright © 2021 Zion Market Research

All Rights Reserved. This document contains highly confidential information and is the sole property of ZMR. No part of it may be

circulated, copied, quoted, or otherwise reproduced without the approval of ZMR



Table of Content

CHAPTER NO. 1 : INTRODUCTION ............................................................................. 14

1.1. Report Description ........................................................................................................ 14

1.1.1. Purpose of the Report ........................................................................................ 14

1.1.2. USP & Key Offerings ........................................................................................... 14

1.2. Key Benefits for Stakeholders ........................................................................................ 14

1.3. Target Audience ............................................................................................................ 15

1.4. Report Scope ................................................................................................................. 15

CHAPTER NO. 2 : EXECUTIVE SUMMARY .................................................................. 17

2.1. Key Findings................................................................................................................... 17

2.1.1. Top Investment Pockets ..................................................................................... 17

2.1.1.1. Market Attractiveness Analysis, By Product ................................................. 17

2.1.1.2. Market Attractiveness Analysis, By Region ................................................... 17

2.2. Market Snapshot ........................................................................................................... 18

2.3. Global Biopharmaceutical Excipients Market, 2016 – 2028 (USD Million) (K Tons)........ 19

2.4. Insights from Primary Respondents ............................................................................... 20

CHAPTER NO. 3 : COVID 19 IMPACT ANALYSIS ......................................................... 21

3.1. Impact Assessment of COVID-19 Pandemic, By Region ................................................. 21

3.1.1. North America ................................................................................................... 21

3.1.2. Europe ............................................................................................................... 21

3.1.3. Asia Pacific ......................................................................................................... 21

3.1.4. Latin America ..................................................................................................... 21

3.1.5. The Middle-East and Africa ................................................................................ 21

3.2. Quarterly Market Revenue & Volume and Forecast by Region 2020 & 2021 ................. 22

3.3. Pre COVID-19 Market Revenue & Volume, By Region, 2016-2019 (USD Million) ........... 24

3.4. Post COVID-19 Market Revenue & Volume, By Region, 2020-2028 (USD Million) ......... 24

3.5. Pre COVID-19 Market Volume, By Region, 2016-2019 (K Tons) ..................................... 25

3.6. Post COVID-19 Market Volume, By Region, 2020-2028 (K Tons) .................................... 25

3.7. Key Strategies Undertaken by Companies to Tackle COVID-19 ...................................... 26

3.8. Short Term Dynamics .................................................................................................... 27

3.9. Long Term Dynamics...................................................................................................... 27



CHAPTER NO. 4 : BIOPHARMACEUTICAL EXCIPIENTS MARKET – PRODUCT SEGMENT ANALYSIS ...................................................................................... 28

4.1. Overview ....................................................................................................................... 28

4.1.1. Market Revenue Share, By Product, 2020 & 2028 .............................................. 28

4.1.2. Market Volume Share, By Product, 2020 & 2028 ................................................ 29

4.2. Specialty Excipients ....................................................................................................... 30

4.2.1. Market Size and Forecast, By Region (USD Million) (K Tons) ............................... 30

4.3. Solubilizers & Surfactants/Emulsifiers ........................................................................... 31


4.4. Polyols ........................................................................................................................... 32


4.5. Carbohydrates ............................................................................................................... 33


CHAPTER NO. 5 : BIOPHARMACEUTICAL EXCIPIENTS MARKET – SOLUBILIZERS & SURFACTANTS/EMULSIFIERS SEGMENT ANALYSIS ....................... 34

5.1. Overview ....................................................................................................................... 34

5.1.1. Market Revenue Share, By Solubilizers & Surfactants/Emulsifiers, 2020 & 2028 ............................................................................................................... 34

5.1.2. Market Volume Share, By Solubilizers & Surfactants/Emulsifiers, 2020 & 2028 ............................................................................................................... 35

5.2. Triglycerides .................................................................................................................. 36


5.3. Esters ............................................................................................................................. 37


5.4. Others ............................................................................................................................ 38


CHAPTER NO. 6 : BIOPHARMACEUTICAL EXCIPIENTS MARKET – POLYOLS SEGMENT ANALYSIS ...................................................................................... 39

6.1. Overview ....................................................................................................................... 39

6.1.1. Market Revenue Share, By Polyols, 2020 & 2028 ............................................... 39

6.1.2. Market Volume Share, By Polyols, 2020 & 2028 ................................................. 40

6.2. Mannitol ........................................................................................................................ 41


6.3. Sorbitol .......................................................................................................................... 42




6.4. Others ............................................................................................................................ 43


CHAPTER NO. 7 : BIOPHARMACEUTICAL EXCIPIENTS MARKET – CARBOHYDRATES SEGMENT ANALYSIS ...................................................................... 44

7.1. Overview ....................................................................................................................... 44

7.1.1. Market Revenue Share, By Carbohydrates, 2020 & 2028 .................................... 44

7.1.2. Market Volume Share, By Carbohydrates, 2020 & 2028 ..................................... 45

7.2. Sucrose .......................................................................................................................... 46


7.3. Dextrose ........................................................................................................................ 47


7.4. Starch ............................................................................................................................ 48


7.5. Others ............................................................................................................................ 49


CHAPTER NO. 8 : BIOPHARMACEUTICAL EXCIPIENTS MARKET – REGIONAL ANALYSIS ...................................................................................................... 50

8.1. Overview ....................................................................................................................... 50

8.1.1. Global Market Revenue Share, By Region, 2020 & 2028 ..................................... 50

8.1.2. Global Market Volume Share, By Region, 2020 & 2028 ...................................... 51

8.1.3. Global Market Revenue & Volume, By Region, 2016 – 2028 (USD Million) (K Tons) ............................................................................................................. 52

8.2. North America ............................................................................................................... 52

8.2.1. North America Market Revenue & Volume, By Country, 2016 – 2028 (USD Million) (K Tons)................................................................................................. 53

8.2.2. North America Market Revenue & Volume, By Product, 2016 – 2028................. 53

8.2.3. North America Market Revenue & Volume, By Solubilizers & Surfactants/Emulsifiers, 2016 – 2028 ................................................................. 53

8.2.4. North America Market Revenue & Volume, By Polyols, 2016 – 2028 .................. 54

8.2.5. North America Market Revenue & Volume, By Carbohydrates, 2016 – 2028 ............................................................................................................... 54

8.2.6. U.S. ............................................................................................................... 54

8.2.7. Canada .............................................................................................................. 54

8.2.8. Mexico............................................................................................................... 54

8.3. Europe ........................................................................................................................... 55



8.3.1. Europe Market Revenue & Volume, By Country, 2016 – 2028 (USD Million) (K Tons) ............................................................................................................. 55

8.3.2. Europe Market Revenue & Volume, By Product, 2016 – 2028 ............................ 55

8.3.3. Europe Market Revenue & Volume, By Solubilizers & Surfactants/Emulsifiers, 2016 – 2028 ................................................................. 55

8.3.4. Europe Market Revenue & Volume, By Polyols, 2016 – 2028 ............................. 55

8.3.5. Europe Market Revenue & Volume, By Carbohydrates, 2016 – 2028 .................. 55

8.3.6. Germany ............................................................................................................ 55

8.3.7. France ............................................................................................................... 55

8.3.8. U.K. ............................................................................................................... 55

8.3.9. Italy ............................................................................................................... 55

8.3.10. Spain ............................................................................................................... 55

8.3.11. Rest of Europe ................................................................................................... 55

8.4. Asia Pacific ..................................................................................................................... 56

8.4.1. Asia Pacific Market Revenue & Volume, By Country, 2016 – 2028 (USD Million) (K Tons)................................................................................................. 56

8.4.2. Asia Pacific Market Revenue & Volume, By Product, 2016 – 2028 ...................... 56

8.4.3. Asia Pacific Market Revenue & Volume, By Solubilizers & Surfactants/Emulsifiers, 2016 – 2028 ................................................................. 56

8.4.4. Asia Pacific Market Revenue & Volume, By Polyols, 2016 – 2028 ....................... 56

8.4.5. Asia Pacific Market Revenue & Volume, By Carbohydrates, 2016 – 2028............ 56

8.4.6. China ............................................................................................................... 56

8.4.7. Japan ............................................................................................................... 56

8.4.8. India ............................................................................................................... 56

8.4.9. South Korea ....................................................................................................... 56

8.4.10. South-East Asia .................................................................................................. 56

8.4.11. Rest of Asia Pacific ............................................................................................. 56

8.5. Latin America................................................................................................................. 57

8.5.1. Latin America Market Revenue & Volume, By Country, 2016 – 2028 (USD Million) (K Tons)................................................................................................. 57

8.5.2. Latin America Market Revenue & Volume, By Product, 2016 – 2028 .................. 57

8.5.3. Latin America Market Revenue & Volume, By Solubilizers & Surfactants/Emulsifiers, 2016 – 2028 ................................................................. 57

8.5.4. Latin America Market Revenue & Volume, By Polyols, 2016 – 2028 ................... 57

8.5.5. Latin America Market Revenue & Volume, By Carbohydrates, 2016 – 2028 ....... 57

8.5.6. Brazil ............................................................................................................... 57

8.5.7. Argentina ........................................................................................................... 57

8.5.8. Rest of Latin America ......................................................................................... 57



8.6. The Middle-East and Africa ............................................................................................ 58

8.6.1. The Middle-East and Africa Market Revenue & Volume, By Country, 2016 – 2028 (USD Million) (K Tons)............................................................................. 58

8.6.2. The Middle-East and Africa Market Revenue & Volume, By Product, 2016 – 2028 ............................................................................................................... 58

8.6.3. The Middle-East and Africa Market Revenue & Volume, By Solubilizers & Surfactants/Emulsifiers, 2016 – 2028 ................................................................. 58

8.6.4. The Middle-East and Africa Market Revenue & Volume, By Polyols, 2016 – 2028 ............................................................................................................... 58

8.6.5. The Middle-East and Africa Market Revenue & Volume, By Carbohydrates, 2016 – 2028 ....................................................................................................... 58

8.6.6. GCC Countries .................................................................................................... 58

8.6.7. South Africa ....................................................................................................... 58

8.6.8. Rest of Middle-East Africa .................................................................................. 58

CHAPTER NO. 9 : BIOPHARMACEUTICAL EXCIPIENTS MARKET – INDUSTRY ANALYSIS ...................................................................................................... 59

9.1. Introduction................................................................................................................... 59

9.2. Market Drivers............................................................................................................... 59

9.2.1. Driving Factor 1 Analysis .................................................................................... 59

9.2.2. Driving Factor 2 Analysis .................................................................................... 60

9.3. Market Restraints .......................................................................................................... 60

9.3.1. Restraining Factor Analysis ................................................................................ 60

9.4. Market Opportunities .................................................................................................... 61

9.4.1. Market Opportunity Analysis ............................................................................. 61

9.5. Porter’s Five Forces Analysis .......................................................................................... 61

9.6. PEST Analysis ................................................................................................................. 62

9.7. Regulatory Landscape .................................................................................................... 63

9.8. Technology Landscape ................................................................................................... 63

9.9. Regional Market Trends ................................................................................................ 63

9.9.1. North America ................................................................................................... 63

9.9.2. Europe ............................................................................................................... 63

9.9.3. Asia Pacific ......................................................................................................... 63

9.9.4. Latin America ..................................................................................................... 63

9.9.5. The Middle-East and Africa ................................................................................ 63

9.10. Value Chain Analysis ...................................................................................................... 64

CHAPTER NO. 10 : COMPETITIVE LANDSCAPE ............................................................ 65



10.1. Company Market Share Analysis – 2020 ........................................................................ 65

10.1.1. Global Biopharmaceutical Excipients Market: Company Market Share, 2020 ............................................................................................................... 65

10.2. Strategic Developments................................................................................................. 66

10.2.1. Acquisitions & Mergers ...................................................................................... 66

10.2.2. New Product Launch .......................................................................................... 66

10.2.3. Regional Expansion ............................................................................................ 66

10.3. Company Strategic Developments – Heat Map Analysis ............................................... 66

CHAPTER NO. 11 : COMPANY PROFILES ..................................................................... 67

11.1. Merck KGaA ................................................................................................................... 67

11.1.1. Company Overview ............................................................................................ 67

11.1.2. Key Executives ................................................................................................... 67

11.1.3. Product Portfolio ............................................................................................... 67

11.1.4. Financial Overview ............................................................................................. 67

11.1.5. Operating Business Segments ............................................................................ 68

11.1.6. Business Performance........................................................................................ 68

11.1.7. Recent Developments ........................................................................................ 69

11.2. Signet Chemical Corporation Pvt. Ltd. ........................................................................... 69

11.3. Sigachi Industries Pvt. Ltd. ............................................................................................. 69

11.4. Spectrum Chemical Manufacturing Corp. ...................................................................... 69

11.5. Roquette Frères ............................................................................................................. 69

11.6. IMCD .............................................................................................................................. 69

11.7. Clariant .......................................................................................................................... 69

11.8. DFE Pharma ................................................................................................................... 69

11.9. BASF SE .......................................................................................................................... 69

11.10. Evonik Industries AG ...................................................................................................... 69

11.11. J. RETTENMAIER & SÖHNE GmbH + Co KG ..................................................................... 69

CHAPTER NO. 12 : MARKETING STRATEGY ANALYSIS................................................. 70

12.1. Marketing Channel ........................................................................................................ 70

12.2. Direct Marketing............................................................................................................ 70

12.3. Indirect Marketing ......................................................................................................... 70

12.4. Marketing Channel Development Trends ...................................................................... 71

CHAPTER NO. 13 : RESEARCH METHODOLOGY .......................................................... 72

13.1. Research Methodology .................................................................................................. 72



13.2. Phase I - Secondary Research ........................................................................................ 73

13.3. Phase II - Data Modeling ................................................................................................ 73

13.3.1. Company Share Analysis Model ......................................................................... 74

13.3.2. Revenue Based Modeling ................................................................................... 74

13.4. Phase III - Primary Research .......................................................................................... 75

13.5. Research Limitations ..................................................................................................... 76

13.5.1. Assumptions ...................................................................................................... 76



List of Figures

FIG NO. 1. Market Attractiveness Analysis, By Product ........................................................................ 17

FIG NO. 2. Market Attractiveness Analysis, By Region.......................................................................... 17

FIG NO. 3. Global Biopharmaceutical Excipients Market Revenue & Volume, 2016 – 2028 (USD

Million) (K Tons) ................................................................................................................. 19

FIG NO. 4. Impact of COVID-19 Pandemic in North America Countries ................................................. 21

FIG NO. 5. Market Revenue Share, By Product, 2020 & 2028 ............................................................... 28

FIG NO. 6. Market Volume Share, By Product, 2020 & 2028 ................................................................ 29

FIG NO. 7. Global Biopharmaceutical Excipients Market for Specialty Excipients, Revenue (USD

Million) Volume (K Tons) 2016 – 2028 ................................................................................ 30

FIG NO. 8. Global Biopharmaceutical Excipients Market for Solubilizers & Surfactants/Emulsifiers,

Revenue (USD Million) Volume (K Tons) 2016 – 2028.......................................................... 31

FIG NO. 9. Global Biopharmaceutical Excipients Market for Polyols, Revenue (USD Million) Volume

(K Tons) 2016 – 2028 .......................................................................................................... 32

FIG NO. 10. Global Biopharmaceutical Excipients Market for Carbohydrates, Revenue (USD Million)

Volume (K Tons) 2016 – 2028 ............................................................................................. 33

FIG NO. 11. Market Revenue Share, By Solubilizers & Surfactants/Emulsifiers, 2020 & 2028 .................. 34

FIG NO. 12. Market Volume Share, By Solubilizers & Surfactants/Emulsifiers, 2020 & 2028 ................... 35

FIG NO. 13. Global Biopharmaceutical Excipients Market for Triglycerides, Revenue (USD Million)

Volume (K Tons) 2016 – 2028 ............................................................................................. 36

FIG NO. 14. Global Biopharmaceutical Excipients Market for Esters, Revenue (USD Million) Volume (K

Tons) 2016 – 2028 .............................................................................................................. 37

FIG NO. 15. Global Biopharmaceutical Excipients Market for Others, Revenue (USD Million) Volume (K

Tons) 2016 – 2028 .............................................................................................................. 38

FIG NO. 16. Market Revenue Share, By Polyols, 2020 & 2028 ................................................................ 39

FIG NO. 17. Market Volume Share, By Polyols, 2020 & 2028 .................................................................. 40

FIG NO. 18. Global Biopharmaceutical Excipients Market for Mannitol, Revenue (USD Million) Volume

(K Tons) 2016 – 2028 .......................................................................................................... 41

FIG NO. 19. Global Biopharmaceutical Excipients Market for Sorbitol, Revenue (USD Million) Volume

(K Tons) 2016 – 2028 .......................................................................................................... 42


Tons) 2016 – 2028 .............................................................................................................. 43

FIG NO. 21. Market Revenue Share, By Carbohydrates, 2020 & 2028 .................................................... 44

FIG NO. 22. Market Volume Share, By Carbohydrates, 2020 & 2028 ...................................................... 45

FIG NO. 23. Global Biopharmaceutical Excipients Market for Sucrose, Revenue (USD Million) Volume

(K Tons) 2016 – 2028 .......................................................................................................... 46

FIG NO. 24. Global Biopharmaceutical Excipients Market for Dextrose, Revenue (USD Million) Volume

(K Tons) 2016 – 2028 .......................................................................................................... 47

FIG NO. 25. Global Biopharmaceutical Excipients Market for Starch, Revenue (USD Million) Volume (K

Tons) 2016 – 2028 .............................................................................................................. 48


Tons) 2016 – 2028 .............................................................................................................. 49

FIG NO. 27. Global Biopharmaceutical Excipients Market Revenue Share, By Region, 2020 & 2028 ........ 50



FIG NO. 28. Global Biopharmaceutical Excipients Market Volume Share, By Region, 2020 & 2028 ......... 51

FIG NO. 29. North America Biopharmaceutical Excipients Market Revenue & Volume, 2016 - 2028

(USD Million) (K Tons) ........................................................................................................ 52

FIG NO. 30. Porter’s Five Forces Analysis for Global Biopharmaceutical Excipients Market .................... 61

FIG NO. 31. PEST Analysis for Global Biopharmaceutical Excipients Market ........................................... 62

FIG NO. 32. Value Chain Analysis for Global Biopharmaceutical Excipients Market ................................ 64

FIG NO. 33. Company Share Analysis, 2020 ........................................................................................... 65

FIG NO. 34. Company Strategic Developments – Heat Map Analysis ...................................................... 66

FIG NO. 35. Merck KGaA Business Segment Revenue Share, 2020 (%) ................................................... 68

FIG NO. 36. Merck KGaA Geographical Segment Revenue Share, 2020 (%) ............................................ 68

FIG NO. 37. Market Channels ................................................................................................................ 70

FIG NO. 38. Marketing Channel Development Trend ............................................................................. 71

FIG NO. 39. Research Methodology – Detailed View ............................................................................. 72

FIG NO. 40. Research Methodology ...................................................................................................... 73



List of Tables

TABLE NO. 1. : Global Biopharmaceutical Excipients Market: Snapshot ...................................................... 18

TABLE NO. 2. : Quarterly Biopharmaceutical Excipients Market Revenue by Region, 2020 ......................... 22

TABLE NO. 3. : Quarterly Biopharmaceutical Excipients Market Revenue Forecast by Region, 2021............ 22

TABLE NO. 4. : Quarterly Biopharmaceutical Excipients Market Volume by Region, 2020 ........................... 23

TABLE NO. 5. : Quarterly Biopharmaceutical Excipients Market Volume Forecast by Region, 2021 ............. 23

TABLE NO. 6. : Pre COVID-19 Market Revenue & Volume, By Region, 2016-2019 (USD Million) .................. 24

TABLE NO. 7. : Post COVID-19 Market Revenue & Volume, By Region, 2020-2028 (USD Million) ................ 24

TABLE NO. 8. : Pre COVID-19 Market Volume, By Region, 2016-2019 (K Tons)............................................ 25

TABLE NO. 9. : Post COVID-19 Market Volume, By Region, 2020-2028 (K Tons) .......................................... 25

TABLE NO. 10. : Global Biopharmaceutical Excipients Market for Specialty Excipients, by Region, 2016 –

2028 (USD Million) (K Tons) ................................................................................................ 30

TABLE NO. 11. : Global Biopharmaceutical Excipients Market for Solubilizers & Surfactants/Emulsifiers, by

Region, 2016 – 2028 (USD Million) (K Tons) ........................................................................ 31

TABLE NO. 12. : Global Biopharmaceutical Excipients Market for Polyols, by Region, 2016 – 2028 (USD

Million) (K Tons) ................................................................................................................. 32

TABLE NO. 13. : Global Biopharmaceutical Excipients Market for Carbohydrates, by Region, 2016 – 2028


TABLE NO. 14. : Global Biopharmaceutical Excipients Market for Triglycerides, by Region, 2016 – 2028


TABLE NO. 15. : Global Biopharmaceutical Excipients Market for Esters, by Region, 2016 – 2028 (USD

Million) (K Tons) ................................................................................................................. 37

TABLE NO. 16. : Global Biopharmaceutical Excipients Market for Others, by Region, 2016 – 2028 (USD

Million) (K Tons) ................................................................................................................. 38

TABLE NO. 17. : Global Biopharmaceutical Excipients Market for Mannitol, by Region, 2016 – 2028 (USD

Million) (K Tons) ................................................................................................................. 41

TABLE NO. 18. : Global Biopharmaceutical Excipients Market for Sorbitol, by Region, 2016 – 2028 (USD

Million) (K Tons) ................................................................................................................. 42


Million) (K Tons) ................................................................................................................. 43

TABLE NO. 20. : Global Biopharmaceutical Excipients Market for Sucrose, by Region, 2016 – 2028 (USD

Million) (K Tons) ................................................................................................................. 46

TABLE NO. 21. : Global Biopharmaceutical Excipients Market for Dextrose, by Region, 2016 – 2028 (USD

Million) (K Tons) ................................................................................................................. 47

TABLE NO. 22. : Global Biopharmaceutical Excipients Market for Starch, by Region, 2016 – 2028 (USD

Million) (K Tons) ................................................................................................................. 48


Million) (K Tons) ................................................................................................................. 49

TABLE NO. 24. : Global Biopharmaceutical Excipients Market Revenue & Volume, By Region, 2016 – 2028


TABLE NO. 25. : North America Biopharmaceutical Excipients Market Revenue & Volume, By Country,

2016 – 2028 (USD Million) (K Tons)..................................................................................... 53



TABLE NO. 26. : North America Biopharmaceutical Excipients Market Revenue & Volume, By Product,

2016 – 2028 (USD Million) (K Tons)..................................................................................... 53

TABLE NO. 27. : North America Biopharmaceutical Excipients Market Revenue & Volume, By Solubilizers

& Surfactants/Emulsifiers, 2016 – 2028 (USD Million) (K Tons) ............................................ 53

TABLE NO. 28. : North America Biopharmaceutical Excipients Market Revenue & Volume, By Polyols, 2016

– 2028 (USD Million) (K Tons) ............................................................................................. 54

TABLE NO. 29. : North America Biopharmaceutical Excipients Market Revenue & Volume, By

Carbohydrates, 2016 – 2028 (USD Million) (K Tons) ............................................................ 54

TABLE NO. 30. : Drivers for the Biopharmaceutical Excipients Market: Impact Analysis ................................ 59

TABLE NO. 31. : Restraints for the Biopharmaceutical Excipients Market: Impact Analysis ........................... 60



Chapter No. 1 : Introduction

1.1. Report Description

1.1.1. Purpose of the Report

The purpose of the strategic research study titled “Biopharmaceutical Excipients Market -

Global Industry Perspective Comprehensive Analysis and Forecast 2020 - 2028” is to offer

industry investors, company executives, and industry participants with in-depth analysis to

enable them make informed strategic decisions related to the opportunities in the industry.

1.1.2. USP & Key Offerings

Market Size in terms of Revenue (USD Million) and Volume (K Tons) from 2016 to 2028

Historical & Descriptive Analysis from 2016 to 2020

Forecasts & Predictive Analysis from 2021 to 2028

Market Drivers, Restraints, Opportunities, & Regional Market Trends

Market Attractiveness Analysis

Segment Analysis by Region and Country

Competitive Landscape and Company Market Share Analysis

Porter’s Five Forces Analysis

Value Chain Analysis

PEST Analysis

Regulatory Landscape

Technology Landscape

COVID-19 Impact Analysis

1.2. Key Benefits for Stakeholders

The report covers forecast and analysis for the Biopharmaceutical Excipients market

on a global and regional level.

The study provides historic data from 2016 to 2020 along with a forecast from 2021

to 2028 based on revenue (USD Million) and volume (K Tons) to determine the

market potential.

The study includes drivers and restraints of the market along with the impact they

have on the demand over the forecast period.



The report includes the study of potential growth opportunities available in the

Biopharmaceutical Excipients market on a global level.

Porter’s five forces analysis illustrates the degree of competition along with the

potency of buyers and suppliers operating in the industry.

1.3. Target Audience

Industry Investors

Healthcare Organizations

End Users

1.4. Report Scope

This report segments the global Biopharmaceutical Excipients market as follows:

Product Segment Analysis

Specialty Excipients

Solubilizers & Surfactants/Emulsifiers

o Triglycerides

o Esters

o Others

Polyols

o Mannitol

o Sorbitol

o Others

Carbohydrates

o Sucrose

o Dextrose

o Starch

o Others

Regional Segment Analysis

North America

o U.S.

o Canada



o Mexico

Europe

o Germany

o France

o U.K.

o Italy

o Spain

o Rest of Europe

Asia Pacific

o China

o Japan

o India

o South Korea

o South-East Asia

o Rest of Asia Pacific

Latin America

o Brazil

o Argentina

o Rest of Latin America

The Middle-East and Africa

o GCC Countries

o South Africa

o Rest of Middle-East Africa



Chapter No. 2 : Executive Summary

2.1. Key Findings

2.1.1. Top Investment Pockets

2.1.1.1. Market Attractiveness Analysis, By Product

FIG NO. 1. Market Attractiveness Analysis, By Product

Source: Zion Market Research Analysis 2021

2.1.1.2. Market Attractiveness Analysis, By Region

FIG NO. 2. Market Attractiveness Analysis, By Region


Mar

ket

Size

Market Attractiveness

Legend 1 Legend 2 Legend 3 Legend 4 Legend 5

HIGH

HIGH

LOW



2.2. Market Snapshot

The global demand for the Biopharmaceutical Excipients market was valued at USD XX

Million in 2020 is expected to reach USD XX Million in 2028 growing at a CAGR of XX%

between 2021 and 2028.

TABLE NO. 1. : Global Biopharmaceutical Excipients Market: Snapshot

PARAMETER 2020 2028

Global Revenue (USD Million) XX XX

Global CAGR (%) 2021 - 2028 Global CAGR: XX%

Product Segment Share (% revenue basis)

Specialty Excipients: XX% Solubilizers & Surfactants/Emulsifiers:

XX% Polyols: XX%

Carbohydrates: XX%

Specialty Excipients: XX% Solubilizers & Surfactants/Emulsifiers:

XX% Polyols: XX%

Carbohydrates: XX%

Product Segment CAGR (%) 2021 - 2028

Specialty Excipients: XX% Solubilizers & Surfactants/Emulsifiers: XX%

Polyols: XX% Carbohydrates: XX%

Geography Share (% revenue basis)

North America: XX% Europe: XX%

Asia Pacific: XX% Latin America: XX%

The Middle-East and Africa: XX%




Geography CAGR (%) 2021 - 2028




Key Participant Share, 2020 (%)

Company 1: XX% Company 2: XX% Company 3: XX%

Drivers Driving Factor 1 Driving Factor 2

Restraint Restraining Factors



2.3. Global Biopharmaceutical Excipients Market, 2016 – 2028 (USD Million) (K Tons)

FIG NO. 3. Global Biopharmaceutical Excipients Market Revenue & Volume, 2016 – 2028 (USD Million) (K Tons)

Source: Primary Interviews, Zion Market Research, 2021

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028

Vo

lum

e (

K T

on

s)

Rev

en

ue

(USD

Mill

ion

)

Revenue Volume



2.4. Insights from Primary Respondents



Chapter No. 3 : COVID 19 Impact Analysis

3.1. Impact Assessment of COVID-19 Pandemic, By Region

3.1.1. North America

FIG NO. 4. Impact of COVID-19 Pandemic in North America Countries

Country Low Moderate High

U.S.

Canada

Mexico


Note: Similar Analysis as that of North America will be provided for all the regions

3.1.2. Europe

3.1.3. Asia Pacific

3.1.4. Latin America

3.1.5. The Middle-East and Africa



3.2. Quarterly Market Revenue & Volume and Forecast by Region 2020 & 2021

TABLE NO. 2. : Quarterly Biopharmaceutical Excipients Market Revenue by Region, 2020

Region 2020 Q1 2020 Q2 2020 Q3 2020 Q4

North America XX XX XX XX

Europe XX XX XX XX

Asia Pacific XX XX XX XX

Latin America XX XX XX XX

The Middle-East and Africa XX XX XX XX

Total XX XX XX XX


TABLE NO. 3. : Quarterly Biopharmaceutical Excipients Market Revenue Forecast by Region, 2021

Region 2021 Q1 2021 Q2 2021 Q3 2021 Q4


Europe XX XX XX XX




Total XX XX XX XX




TABLE NO. 4. : Quarterly Biopharmaceutical Excipients Market Volume by Region, 2020

Region 2020 Q1 2020 Q2 2020 Q3 2020 Q4


Europe XX XX XX XX




Total XX XX XX XX


TABLE NO. 5. : Quarterly Biopharmaceutical Excipients Market Volume Forecast by Region, 2021

Region 2021 Q1 2021 Q2 2021 Q3 2021 Q4


Europe XX XX XX XX




Total XX XX XX XX




3.3. Pre COVID-19 Market Revenue & Volume, By Region, 2016-2019 (USD Million)

TABLE NO. 6. : Pre COVID-19 Market Revenue & Volume, By Region, 2016-2019 (USD Million)

Region 2016 2017 2018 2019


Europe XX XX XX XX




Total XX XX XX XX


3.4. Post COVID-19 Market Revenue & Volume, By Region, 2020-2028 (USD Million)

TABLE NO. 7. : Post COVID-19 Market Revenue & Volume, By Region, 2020-2028 (USD Million)

Region 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR (%) 2021 -

2028

North America XX XX XX XX XX XX XX XX XX XX%

Europe XX XX XX XX XX XX XX XX XX XX%

Asia Pacific XX XX XX XX XX XX XX XX XX XX%

Latin America XX XX XX XX XX XX XX XX XX XX%

The Middle-East and Africa XX XX XX XX XX XX XX XX XX XX%

Total XX XX XX XX XX XX XX XX XX XX%




3.5. Pre COVID-19 Market Volume, By Region, 2016-2019 (K Tons)

TABLE NO. 8. : Pre COVID-19 Market Volume, By Region, 2016-2019 (K Tons)

Region 2016 2017 2018 2019


Europe XX XX XX XX




Total XX XX XX XX


3.6. Post COVID-19 Market Volume, By Region, 2020-2028 (K Tons)

TABLE NO. 9. : Post COVID-19 Market Volume, By Region, 2020-2028 (K Tons)

Region 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR (%) 2021 -

2028

North America XX XX XX XX XX XX XX XX XX XX%

Europe XX XX XX XX XX XX XX XX XX XX%

Asia Pacific XX XX XX XX XX XX XX XX XX XX%

Latin America XX XX XX XX XX XX XX XX XX XX%

The Middle-East and Africa XX XX XX XX XX XX XX XX XX XX%

Total XX XX XX XX XX XX XX XX XX XX%




3.7. Key Strategies Undertaken by Companies to Tackle COVID-19



3.8. Short Term Dynamics

3.9. Long Term Dynamics



Chapter No. 4 : Biopharmaceutical Excipients Market – Product Segment Analysis

4.1. Overview

4.1.1. Market Revenue Share, By Product, 2020 & 2028

FIG NO. 5. Market Revenue Share, By Product, 2020 & 2028




4.1.2. Market Volume Share, By Product, 2020 & 2028

FIG NO. 6. Market Volume Share, By Product, 2020 & 2028




4.2. Specialty Excipients

FIG NO. 7. Global Biopharmaceutical Excipients Market for Specialty Excipients, Revenue (USD Million) Volume (K Tons) 2016 – 2028


4.2.1. Market Size and Forecast, By Region (USD Million) (K Tons)

TABLE NO. 10. : Global Biopharmaceutical Excipients Market for Specialty Excipients, by Region, 2016 – 2028 (USD Million) (K Tons)

Region 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR

North America XX XX XX XX XX XX XX XX XX XX XX XX XX XX%

Europe XX XX XX XX XX XX XX XX XX XX XX XX XX XX%

Asia Pacific

XX XX XX XX XX XX XX XX XX XX XX XX XX XX%

Latin America




Total XX XX XX XX XX XX XX XX XX XX XX XX XX XX%




4.3. Solubilizers & Surfactants/Emulsifiers

FIG NO. 8. Global Biopharmaceutical Excipients Market for Solubilizers & Surfactants/Emulsifiers, Revenue (USD Million) Volume (K Tons) 2016 – 2028



TABLE NO. 11. : Global Biopharmaceutical Excipients Market for Solubilizers & Surfactants/Emulsifiers, by Region, 2016 – 2028 (USD Million) (K Tons)

Region 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR



Asia Pacific


Latin America








4.4. Polyols

FIG NO. 9. Global Biopharmaceutical Excipients Market for Polyols, Revenue (USD Million) Volume (K Tons) 2016 – 2028



TABLE NO. 12. : Global Biopharmaceutical Excipients Market for Polyols, by Region, 2016 – 2028 (USD Million) (K Tons)

Region 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR



Asia Pacific


Latin America








4.5. Carbohydrates

FIG NO. 10. Global Biopharmaceutical Excipients Market for Carbohydrates, Revenue (USD Million) Volume (K Tons) 2016 – 2028



TABLE NO. 13. : Global Biopharmaceutical Excipients Market for Carbohydrates, by Region, 2016 – 2028 (USD Million) (K Tons)

Region 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR



Asia Pacific


Latin America








Chapter No. 5 : Biopharmaceutical Excipients Market – Solubilizers & Surfactants/Emulsifiers Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Solubilizers & Surfactants/Emulsifiers, 2020 & 2028

FIG NO. 11. Market Revenue Share, By Solubilizers & Surfactants/Emulsifiers, 2020 & 2028




5.1.2. Market Volume Share, By Solubilizers & Surfactants/Emulsifiers, 2020 & 2028

FIG NO. 12. Market Volume Share, By Solubilizers & Surfactants/Emulsifiers, 2020 & 2028




5.2. Triglycerides

FIG NO. 13. Global Biopharmaceutical Excipients Market for Triglycerides, Revenue (USD Million) Volume (K Tons) 2016 – 2028



TABLE NO. 14. : Global Biopharmaceutical Excipients Market for Triglycerides, by Region, 2016 – 2028 (USD Million) (K Tons)

Region 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR



Asia Pacific


Latin America








5.3. Esters

FIG NO. 14. Global Biopharmaceutical Excipients Market for Esters, Revenue (USD Million) Volume (K Tons) 2016 – 2028



TABLE NO. 15. : Global Biopharmaceutical Excipients Market for Esters, by Region, 2016 – 2028 (USD Million) (K Tons)

Region 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR



Asia Pacific


Latin America








5.4. Others

FIG NO. 15. Global Biopharmaceutical Excipients Market for Others, Revenue (USD Million) Volume (K Tons) 2016 – 2028



TABLE NO. 16. : Global Biopharmaceutical Excipients Market for Others, by Region, 2016 – 2028 (USD Million) (K Tons)

Region 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR



Asia Pacific


Latin America








Chapter No. 6 : Biopharmaceutical Excipients Market – Polyols Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Polyols, 2020 & 2028

FIG NO. 16. Market Revenue Share, By Polyols, 2020 & 2028




6.1.2. Market Volume Share, By Polyols, 2020 & 2028

FIG NO. 17. Market Volume Share, By Polyols, 2020 & 2028




6.2. Mannitol

FIG NO. 18. Global Biopharmaceutical Excipients Market for Mannitol, Revenue (USD Million) Volume (K Tons) 2016 – 2028



TABLE NO. 17. : Global Biopharmaceutical Excipients Market for Mannitol, by Region, 2016 – 2028 (USD Million) (K Tons)

Region 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR



Asia Pacific


Latin America








6.3. Sorbitol

FIG NO. 19. Global Biopharmaceutical Excipients Market for Sorbitol, Revenue (USD Million) Volume (K Tons) 2016 – 2028



TABLE NO. 18. : Global Biopharmaceutical Excipients Market for Sorbitol, by Region, 2016 – 2028 (USD Million) (K Tons)

Region 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR



Asia Pacific


Latin America








6.4. Others





Region 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR



Asia Pacific


Latin America








Chapter No. 7 : Biopharmaceutical Excipients Market – Carbohydrates Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By Carbohydrates, 2020 & 2028

FIG NO. 21. Market Revenue Share, By Carbohydrates, 2020 & 2028




7.1.2. Market Volume Share, By Carbohydrates, 2020 & 2028

FIG NO. 22. Market Volume Share, By Carbohydrates, 2020 & 2028




7.2. Sucrose

FIG NO. 23. Global Biopharmaceutical Excipients Market for Sucrose, Revenue (USD Million) Volume (K Tons) 2016 – 2028



TABLE NO. 20. : Global Biopharmaceutical Excipients Market for Sucrose, by Region, 2016 – 2028 (USD Million) (K Tons)

Region 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR



Asia Pacific


Latin America








7.3. Dextrose

FIG NO. 24. Global Biopharmaceutical Excipients Market for Dextrose, Revenue (USD Million) Volume (K Tons) 2016 – 2028



TABLE NO. 21. : Global Biopharmaceutical Excipients Market for Dextrose, by Region, 2016 – 2028 (USD Million) (K Tons)

Region 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR



Asia Pacific


Latin America








7.4. Starch

FIG NO. 25. Global Biopharmaceutical Excipients Market for Starch, Revenue (USD Million) Volume (K Tons) 2016 – 2028



TABLE NO. 22. : Global Biopharmaceutical Excipients Market for Starch, by Region, 2016 – 2028 (USD Million) (K Tons)

Region 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR



Asia Pacific


Latin America








7.5. Others





Region 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR



Asia Pacific


Latin America








Chapter No. 8 : Biopharmaceutical Excipients Market – Regional Analysis

8.1. Overview

Regionally, the market for Biopharmaceutical Excipients is fragmented into North America,

Latin America, Asia-Pacific, Europe, and Middle East & Africa.

8.1.1. Global Market Revenue Share, By Region, 2020 & 2028

FIG NO. 27. Global Biopharmaceutical Excipients Market Revenue Share, By Region, 2020 & 2028


2020 2028



8.1.2. Global Market Volume Share, By Region, 2020 & 2028

FIG NO. 28. Global Biopharmaceutical Excipients Market Volume Share, By Region, 2020 & 2028


2020 2028



8.1.3. Global Market Revenue & Volume, By Region, 2016 – 2028 (USD Million) (K Tons)

TABLE NO. 24. : Global Biopharmaceutical Excipients Market Revenue & Volume, By Region, 2016 – 2028 (USD Million) (K Tons)

Region 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR

North America



Asia Pacific XX XX XX XX XX XX XX XX XX XX XX XX XX XX%

Latin America XX XX XX XX XX XX XX XX XX XX XX XX XX XX%





8.2. North America

FIG NO. 29. North America Biopharmaceutical Excipients Market Revenue & Volume, 2016 - 2028 (USD Million) (K Tons)




8.2.1. North America Market Revenue & Volume, By Country, 2016 – 2028 (USD Million) (K Tons)

TABLE NO. 25. : North America Biopharmaceutical Excipients Market Revenue & Volume, By Country, 2016 – 2028 (USD Million) (K Tons)

Country 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR

U.S. XX XX XX XX XX XX XX XX XX XX XX XX XX XX%

Canada XX XX XX XX XX XX XX XX XX XX XX XX XX XX%

Mexico XX XX XX XX XX XX XX XX XX XX XX XX XX XX%



8.2.2. North America Market Revenue & Volume, By Product, 2016 – 2028

TABLE NO. 26. : North America Biopharmaceutical Excipients Market Revenue & Volume, By Product, 2016 – 2028 (USD Million) (K Tons)

Product 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR

Specialty Excipients


Solubilizers &

Surfactants/Emulsifiers


Polyols XX XX XX XX XX XX XX XX XX XX XX XX XX XX%

Carbohydrates




8.2.3. North America Market Revenue & Volume, By Solubilizers & Surfactants/Emulsifiers, 2016 – 2028

TABLE NO. 27. : North America Biopharmaceutical Excipients Market Revenue & Volume, By Solubilizers & Surfactants/Emulsifiers, 2016 – 2028 (USD Million) (K Tons)

Solubilizers &

Surfactants/Emulsifiers

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR

Triglycerides XX XX XX XX XX XX XX XX XX XX XX XX XX XX%

Esters XX XX XX XX XX XX XX XX XX XX XX XX XX XX%

Others XX XX XX XX XX XX XX XX XX XX XX XX XX XX%





8.2.4. North America Market Revenue & Volume, By Polyols, 2016 – 2028

TABLE NO. 28. : North America Biopharmaceutical Excipients Market Revenue & Volume, By Polyols, 2016 – 2028 (USD Million) (K Tons)

Polyols 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR

Mannitol XX XX XX XX XX XX XX XX XX XX XX XX XX XX%

Sorbitol XX XX XX XX XX XX XX XX XX XX XX XX XX XX%




8.2.5. North America Market Revenue & Volume, By Carbohydrates, 2016 – 2028

TABLE NO. 29. : North America Biopharmaceutical Excipients Market Revenue & Volume, By Carbohydrates, 2016 – 2028 (USD Million) (K Tons)

Carbohydrates

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR

Sucrose XX XX XX XX XX XX XX XX XX XX XX XX XX XX%

Dextrose XX XX XX XX XX XX XX XX XX XX XX XX XX XX%

Starch XX XX XX XX XX XX XX XX XX XX XX XX XX XX%




8.2.6. U.S.

8.2.7. Canada

8.2.8. Mexico

Note: Similar analysis as that of North America will be provided for the below mentioned regions and countries:



8.3. Europe

8.3.1. Europe Market Revenue & Volume, By Country, 2016 – 2028 (USD Million) (K Tons)

8.3.2. Europe Market Revenue & Volume, By Product, 2016 – 2028

8.3.3. Europe Market Revenue & Volume, By Solubilizers & Surfactants/Emulsifiers, 2016 – 2028

8.3.4. Europe Market Revenue & Volume, By Polyols, 2016 – 2028

8.3.5. Europe Market Revenue & Volume, By Carbohydrates, 2016 – 2028

8.3.6. Germany

8.3.7. France

8.3.8. U.K.

8.3.9. Italy

8.3.10. Spain

8.3.11. Rest of Europe



8.4. Asia Pacific

8.4.1. Asia Pacific Market Revenue & Volume, By Country, 2016 – 2028 (USD Million) (K Tons)

8.4.2. Asia Pacific Market Revenue & Volume, By Product, 2016 – 2028

8.4.3. Asia Pacific Market Revenue & Volume, By Solubilizers & Surfactants/Emulsifiers, 2016 – 2028

8.4.4. Asia Pacific Market Revenue & Volume, By Polyols, 2016 – 2028

8.4.5. Asia Pacific Market Revenue & Volume, By Carbohydrates, 2016 – 2028

8.4.6. China

8.4.7. Japan

8.4.8. India

8.4.9. South Korea

8.4.10. South-East Asia

8.4.11. Rest of Asia Pacific



8.5. Latin America

8.5.1. Latin America Market Revenue & Volume, By Country, 2016 – 2028 (USD Million) (K Tons)

8.5.2. Latin America Market Revenue & Volume, By Product, 2016 – 2028

8.5.3. Latin America Market Revenue & Volume, By Solubilizers & Surfactants/Emulsifiers, 2016 – 2028

8.5.4. Latin America Market Revenue & Volume, By Polyols, 2016 – 2028

8.5.5. Latin America Market Revenue & Volume, By Carbohydrates, 2016 – 2028

8.5.6. Brazil

8.5.7. Argentina

8.5.8. Rest of Latin America



8.6. The Middle-East and Africa

8.6.1. The Middle-East and Africa Market Revenue & Volume, By Country, 2016 – 2028 (USD Million) (K Tons)

8.6.2. The Middle-East and Africa Market Revenue & Volume, By Product, 2016 – 2028

8.6.3. The Middle-East and Africa Market Revenue & Volume, By Solubilizers & Surfactants/Emulsifiers, 2016 – 2028

8.6.4. The Middle-East and Africa Market Revenue & Volume, By Polyols, 2016 – 2028

8.6.5. The Middle-East and Africa Market Revenue & Volume, By Carbohydrates, 2016 – 2028

8.6.6. GCC Countries

8.6.7. South Africa

8.6.8. Rest of Middle-East Africa



Chapter No. 9 : Biopharmaceutical Excipients Market – Industry Analysis

9.1. Introduction

9.2. Market Drivers

TABLE NO. 30. : Drivers for the Biopharmaceutical Excipients Market: Impact Analysis

Market Drivers 2016-19 2020-23 2024-28

Impact

Market Driver 1 XX XX XX

Market Driver 2 XX XX XX


9.2.1. Driving Factor 1 Analysis



9.2.2. Driving Factor 2 Analysis

9.3. Market Restraints

TABLE NO. 31. : Restraints for the Biopharmaceutical Excipients Market: Impact Analysis

Market Restraints 2016-19 2020-23 2024-28

Impact

Market Restraints 1 XX XX XX

Market Restraints 2 XX XX XX

9.3.1. Restraining Factor Analysis



9.4. Market Opportunities

9.4.1. Market Opportunity Analysis

9.5. Porter’s Five Forces Analysis

FIG NO. 30. Porter’s Five Forces Analysis for Global Biopharmaceutical Excipients Market


XX

DEGREE OF COMPITITION

HIGH XX

SUPPLIER’S POWER

MODERATE XX

BUYER’S POWER

MODERATE XX

TRHEAT OF SUBSTITUTE MODERATE

XX

TRHEAT OF NEW ENTRANTS

MEDIUM



9.6. PEST Analysis

FIG NO. 31. PEST Analysis for Global Biopharmaceutical Excipients Market


XX

XX

XX

XX



9.7. Regulatory Landscape

9.8. Technology Landscape

9.9. Regional Market Trends

9.9.1. North America

9.9.2. Europe

9.9.3. Asia Pacific

9.9.4. Latin America

9.9.5. The Middle-East and Africa



9.10. Value Chain Analysis

FIG NO. 32. Value Chain Analysis for Global Biopharmaceutical Excipients Market


RAW MATERIAL / COMPONENT SUPPLIERS

Key Raw Material / Components: • --------------------- • --------------------- • ---------------------

Key Raw Material / Components: • --------------------- • --------------------- • ---------------------

MANUFACTURERS / ASSEMBLERS / OEMS

Key Product Types: • --------------------- • --------------------- • ---------------------

Key Manufacturers/ Assemblers/OEMs • --------------------- • --------------------- • ---------------------

DISTRIBUTORS

Key Distributors:

---------------------

---------------------

---------------------

---------------------

---------------------

---------------------

---------------------

RETAILERS AND ONLINE SALES

Key Retailing Channels:

---------------------

---------------------

---------------------

Sales Channels:

---------------------

---------------------

---------------------

END-USERS

Key End-Users:

---------------------

---------------------

---------------------

KEY BUYERS:

---------------------

---------------------

---------------------



Chapter No. 10 : Competitive Landscape

10.1. Company Market Share Analysis – 2020

10.1.1. Global Biopharmaceutical Excipients Market: Company Market Share, 2020

FIG NO. 33. Company Share Analysis, 2020


Note: The above chart is for representation purpose only

14%

12%

11%

10%9%

7%

6%

5%

3%

23%

Company 1Company 2Company 3Company 4Company 5Company 6Company 7Company 8Company 9Others



10.2. Strategic Developments

10.2.1. Acquisitions & Mergers

Date Company Development

March, 2017 XXXXX XXXXX

April, 2018 XXXXX XXXXX

September, 2018 XXXXX XXXXX


10.2.2. New Product Launch


January, 2020 XXXXX XXXXX

August, 2019 XXXXX XXXXX

December, 2018 XXXXX XXXXX


10.2.3. Regional Expansion


May, 2019 XXXXX XXXXX

April, 2017 XXXXX XXXXX

October, 2016 XXXXX XXXXX


10.3. Company Strategic Developments – Heat Map Analysis

FIG NO. 34. Company Strategic Developments – Heat Map Analysis

Company Name Acquisitions & Mergers

New Product Launch Regional Expansion Partnership /

Collaborations

Company 1

Company 2

Company 3

Company 4

Company 5

Depicts High

Depicts Moderate

Depicts Low




Chapter No. 11 : Company Profiles

11.1. Merck KGaA

Address: XX

Contact No.: XX

Website: XX

11.1.1. Company Overview

xxx

11.1.2. Key Executives

Name Designation

XX CEO

XX President

XX XX

11.1.3. Product Portfolio

Product Information

XX XXX

XX XXX


11.1.4. Financial Overview

Year 2018 2019 2020

Revenue (USD Million) XX XX XX

R&D Expenditure (USD Million) XX XX XX

Gross Margin XX XX XX

Operating Income XX XX XX




11.1.5. Operating Business Segments

Segment Description

XX XXX

XX XXX


11.1.6. Business Performance

FIG NO. 35. Merck KGaA Business Segment Revenue Share, 2020 (%)



FIG NO. 36. Merck KGaA Geographical Segment Revenue Share, 2020 (%)





11.1.7. Recent Developments

Date Development

February, 2019 XXX

July, 2019 XXX

October, 2019 XXX


Similar analysis will be provided for the following companies:

11.2. Signet Chemical Corporation Pvt. Ltd.

11.3. Sigachi Industries Pvt. Ltd.

11.4. Spectrum Chemical Manufacturing Corp.

11.5. Roquette Frères

11.6. IMCD

11.7. Clariant

11.8. DFE Pharma

11.9. BASF SE

11.10. Evonik Industries AG

11.11. J. RETTENMAIER & SÖHNE GmbH + Co KG

Note: The number of companies mentioned above are not limited. We can include additional companies of your inter est.



Chapter No. 12 : Marketing Strategy Analysis

12.1. Marketing Channel

With the advancement of technology, immense changes are opted for business strategies by

manufacturers of the Biopharmaceutical Excipients. Manufacturers of Biopharmaceutical

Excipients have utilized ----- marketing to sell their products. The development of global

competition, technology, and advertising industry have made maintenance, pricing and

promotion strategies for the product more complicated. Concerning these challenges, the

importance of the marketing channel, as a strategic tool, has rapidly grown.

FIG NO. 37. Market Channels


12.2. Direct Marketing

12.3. Indirect Marketing



12.4. Marketing Channel Development Trends

Online marketing will be a trend in the future. E-commerce sales have continued to grow

during recent years consistent with increased online shopping by various end-users.

FIG NO. 38. Marketing Channel Development Trend




Chapter No. 13 : Research Methodology

13.1. Research Methodology

The research methodology at ZMR is iterative in nature is usually conducted in three phases:

Secondary Research

Data Modeling

Primary Research

FIG NO. 39. Research Methodology – Detailed View




13.2. Phase I - Secondary Research

Understanding the scope, we commenced our study with in-depth and extensive secondary

research. Data for secondary research is procured from public and paid sources. The

secondary research sources that are typically referred to include, but are not limited to:

Company websites, annual reports, financial reports, broker reports, investor presentations, and SEC filings

Internal and external proprietary databases, relevant patent and regulatory databases

National government documents, statistical databases, and market reports

News articles, press releases and web-casts specific to the companies operating in the market

Some sources for paid secondary research include, but are not limited to: Factiva, Hoovers,

and Statista

FIG NO. 40. Research Methodology


13.3. Phase II - Data Modeling

Data procured from secondary sources is then used across different market sizing models

and estimates are derived in order to produce comprehensive data sets. A rigorous

methodology is adopted in which the available hard data is cross referenced with the

following data types to produce estimates:

Demographic data: Population split

Macro-economic indicators: GDP

Industry indicators: Expenditure, product stage & infrastructure, sector growth and facilities.

Data is then cross checked by the expert panel.



13.3.1. Company Share Analysis Model

Company share analysis is used to derive the size of global market. As well as study of

revenues of companies for last three to five years also provide the base for forecasting the

market size and its growth rate. This model is built in following steps:

13.3.2. Revenue Based Modeling

Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of

industry. Market size estimated from company share analysis acts as a validation point for

bottom-up approach whereas it acts as a starting point for top-down approach.

Summation of regional markets to derive the global market

Summation of country level revenue to derive regional market

Summation of revenue generated from all the sub-segments to derive the total market size of that particular country Revenue generated from particular sub-segment from particular country

Global market size of Enterprise Performance Management market

Splitting global market into different regions

Splitting country level market into segments and sub-segments

Splitting regional market into different countries



13.4. Phase III - Primary Research

Information from secondary is used to build data models. The results obtained from data

models are then validated from primary participants. Then cycle repeats where, according

to inputs from primary participants, additional secondary research is done and new

information is again incorporated into the data model. The process continues till the desired

level of information is generated.

We conduct primary interviews on an ongoing basis with industry participants and

commentators in order to validate data and analysis. A typical research interview fulfills the

following functions:

It provides first-hand information on the market size, market trends, growth trends, competitive landscape, and future outlook.

Helps in validating and strengthening the secondary research findings

Further develops the analysis team’s expertise and market understanding

Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

The participants who typically take part in such a process include, but are not limited to:

Industry participants: CEOs, VPs, marketing/ product managers, market intelligence managers, and national sales managers

Purchasing managers, technical personnel, distributors and resellers

Outside experts: Investors, valuation experts, research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals



13.5. Research Limitations

Inflation is not a part of pricing in this report. Prices of Biopharmaceutical Excipients and its

derivatives vary in each region and hence similar revenue ratio does not follow for each

individual region. The same price for each type has been taken into account while

estimating and forecasting market revenue on a global basis. The regional average price has

been considered while breaking down this market by applications in each region.

This report provides market size of Biopharmaceutical Excipients for the past four years and

forecasts for the next seven years. The global Biopharmaceutical Excipients market size is

given in terms of revenue. Market revenue is defined in USD Million. Market numbers are

given on the basis of different Biopharmaceutical Excipients. Market size and forecasts for

each major distribution channel is provided in the context of global as well as the regional

market.

The numbers provided in this report are derived on the basis of demand for

Biopharmaceutical Excipients from different applications in different regions.

13.5.1. Assumptions

FACTORS ASSUMPTIONS

Exchange Rates We have assumed that U.S. dollar fluctuations will not be severe enough to affect the forecasts to a significant extent.

Political Unrest We have assumed political stability in the regions covered and any instability will not hamper the economic growth to the level which will affect our forecasts.

Government Spending A stable government spending pattern is considered during the forecast period.



Disclaimer

Any part of this report cannot be reproduced, kept in a retrieval system or transmitted in

any kind by any means, electronic, mechanical, photocopying, recording or otherwise,

without the prior permission of the publisher, Zion Market Research.

The information and opinions in this report were prepared by Zion Market Research. The

information herein is believed to be reliable and has been obtained from public source

believed to be reliable. All info provided in this report is provided for information purposes

solely.

The facts of this report are believed to be correct at the time of publication however cannot

be assured. Please note that the judgments, conclusions and recommendations that Zion

Market Research delivers can be based on information gathered in good faith from each

primary and secondary sources, we have a tendency to be always in a position to ensure.

Research can initiate, update and cease coverage alone at the discretion of Zion Market

Research.

Zion Market Research has no obligation to notify a recipient thereof within the event that

any estimation, forecast, changes or subsequently becomes inaccurate.

As such Zion Market Research will accept no liability whatever for actions taken based

mostly on any information that could subsequently prove to be incorrect.

Asia Pacific Office

3rd Floor, Mrunal Paradise,

Opp. Maharaja Hotel, Pimple Gurav,

Pune 411061,

Maharashtra, India

Phone No 020 -65322355

Corporate Office

244 Fifth Avenue, Suite N202, New York

10001, United States

USA/Canada

Toll Free No.1-855-465-4651

Mail ID: [email protected]

Documents

GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS,